Transdermal Adhesives Market Size, Share, Growth, and Industry Analysis, By Type (Silicon Base, Acrylic, Rubber Base), By Application (Hospital, Clinic, Other), Regional Insights and Forecast to 2035

Transdermal Adhesives Market Overview

Transdermal Adhesives Market size is anticipated to be valued at USD 83.46 million in 2026, with a projected growth to USD 135.77 million by 2035 at a CAGR of 5.56%.

The Transdermal Adhesives Market is an essential component of the global transdermal drug delivery ecosystem, supporting the secure attachment of medicated patches to the skin while enabling controlled drug release. Increasing utilization of transdermal therapeutic systems for pain management, hormone replacement therapy, cardiovascular disorders, smoking cessation, and neurological treatments continues to expand demand for advanced adhesive technologies. More than 60% of commercially available transdermal patches rely on acrylic-based adhesive formulations due to their balance of adhesion, compatibility, and skin tolerability. Silicone-based products are increasingly adopted in long-wear applications, accounting for over 20% of premium patch formulations. The growing prevalence of chronic diseases affects hundreds of millions of patients globally, encouraging wider adoption of non-invasive drug delivery alternatives. Pharmaceutical manufacturers are focusing on high-performance pressure-sensitive adhesives capable of maintaining adhesion for 3 to 7 days under varying environmental conditions, making the Transdermal Adhesives Market Analysis a critical area within healthcare materials innovation and pharmaceutical manufacturing.

The United States represents one of the most advanced markets for transdermal adhesive technologies due to strong pharmaceutical manufacturing capabilities and extensive adoption of transdermal therapeutic systems. More than 130 million adults in the country live with at least one chronic condition, increasing the need for convenient drug delivery methods. Approximately 6 in 10 adults require long-term medication management, creating favorable demand for transdermal patches utilizing advanced adhesive systems. Over 70% of prescription transdermal products distributed in the country employ acrylic-based adhesive technologies, while silicone adhesives continue gaining traction in sensitive-skin applications. The country maintains a substantial concentration of pharmaceutical research facilities, with thousands of clinical studies evaluating transdermal delivery platforms. Rising utilization of nicotine replacement therapies, pain management patches, hormonal therapies, and wearable drug delivery devices continues to support innovation across the U.S. Transdermal Adhesives Industry Analysis landscape.

Download FREE Sample to learn more about this report.

Key Findings

• Key Market Driver: More than 68% of chronic therapy patients prefer non-invasive drug administration methods, while transdermal compliance rates exceed oral medication adherence by approximately 24%, supporting wider adhesive utilization across therapeutic applications.
• Major Market Restraint: Nearly 31% of users experience mild skin irritation, 18% report adhesive residue concerns, and approximately 14% encounter reduced patch adhesion during high-humidity exposure conditions.
• Emerging Trends: Around 42% of newly developed patches incorporate skin-friendly formulations, while silicone adhesive adoption has increased by nearly 28% within advanced wearable and long-duration therapeutic applications.
• Regional Leadership: North America accounts for approximately 39% of global demand, Europe contributes nearly 30%, and Asia-Pacific represents over 24% with rapidly expanding pharmaceutical manufacturing activities.
• Competitive Landscape: The top ten manufacturers collectively supply more than 57% of specialized pharmaceutical-grade adhesive materials, while innovation investments exceed 35% of total product development activities.
• Market Segmentation: Acrylic adhesives represent approximately 62% of product utilization, silicone-based materials account for around 23%, and rubber-based formulations contribute nearly 15% of overall demand.
• Recent Development: More than 46% of newly launched adhesive formulations emphasize enhanced skin compatibility, while 33% focus on extended wear duration and improved moisture resistance performance.

Transdermal Adhesives Market Latest Trends

The Transdermal Adhesives Market Trends landscape is being transformed by advancements in skin-friendly formulations, wearable healthcare integration, and extended-wear adhesive technologies. Pharmaceutical companies are increasingly introducing matrix-type transdermal systems that combine drug reservoirs directly within adhesive layers, reducing patch thickness by up to 35% compared with conventional designs. Silicone-based adhesives are witnessing notable adoption because they can reduce skin trauma by approximately 25% during patch removal compared with traditional alternatives. Wearable healthcare devices integrated with drug delivery systems have increased utilization of specialty adhesives capable of maintaining adhesion through perspiration and physical activity. More than 40% of newly evaluated transdermal platforms include enhanced moisture-management properties. Manufacturers are also developing low-allergen formulations to address skin sensitivity concerns affecting nearly one-third of patch users. The integration of micro-reservoir technologies and advanced pressure-sensitive adhesives is improving drug permeation efficiency by up to 20% in selected therapeutic applications. Digital health monitoring compatibility, flexible patch designs, breathable backing materials, and enhanced adhesion under varying environmental conditions continue shaping Transdermal Adhesives Market Growth and Transdermal Adhesives Market Opportunities across pharmaceutical and healthcare sectors.

Transdermal Adhesives Market Dynamics

DRIVER

"Rising Demand for Non-Invasive Drug Delivery Systems"

The primary growth driver in the Transdermal Adhesives Market is the increasing preference for non-invasive drug delivery technologies among healthcare providers and patients. Studies indicate that medication adherence rates can improve by more than 20% when transdermal delivery systems replace frequent oral dosing schedules. Globally, chronic diseases affect hundreds of millions of individuals, creating sustained demand for long-duration therapeutic solutions. Approximately 65% of patients receiving long-term treatment report greater convenience with patch-based drug administration compared with conventional methods. Pharmaceutical developers are expanding transdermal therapies for pain management, cardiovascular conditions, hormonal treatments, neurological disorders, and smoking cessation programs. Modern pressure-sensitive adhesives can maintain secure skin attachment for periods ranging from 72 hours to seven days while preserving drug delivery consistency. More than 50% of current transdermal product development projects focus on enhancing patient comfort and improving wear duration. The increasing elderly population, higher prevalence of chronic conditions, and growing preference for self-administered therapies continue accelerating demand throughout the Transdermal Adhesives Market Research Report ecosystem.

RESTRAINTS

"Skin Irritation and Adhesion Performance Limitations"

One of the major restraints affecting the Transdermal Adhesives Market is the occurrence of skin irritation and inconsistent adhesion performance under diverse environmental conditions. Clinical observations indicate that approximately 20% to 35% of transdermal patch users experience mild erythema, itching, redness, or discomfort after prolonged wear. Adhesive residue remaining on the skin affects nearly 18% of users in certain therapeutic applications. Environmental factors such as humidity, perspiration, temperature fluctuations, and physical activity can significantly influence adhesive effectiveness. In high-moisture conditions, some formulations may experience adhesion reductions exceeding 15%. Product developers must balance strong adhesion with gentle removal characteristics, a challenge requiring continuous material innovation. Regulatory compliance requirements for biocompatibility testing, sensitization evaluation, and dermatological safety further increase product development complexity. In addition, formulation incompatibility between certain active pharmaceutical ingredients and adhesive matrices can restrict product design flexibility. These factors create technical and operational challenges across the Transdermal Adhesives Industry Report landscape despite strong demand fundamentals.

OPPORTUNITY

"Expansion of Personalized and Wearable Healthcare Solutions"

The expansion of personalized medicine and wearable healthcare technologies presents substantial opportunities for the Transdermal Adhesives Market. Healthcare providers are increasingly utilizing patient-specific treatment approaches, encouraging development of customized transdermal delivery platforms. More than 45% of wearable healthcare devices currently under development require advanced skin-contact adhesive materials capable of maintaining performance during continuous monitoring or treatment. Smart patches integrating sensors, microelectronics, and therapeutic delivery components are emerging across chronic disease management applications. Flexible adhesive systems designed for curved body surfaces can improve user comfort by approximately 30% compared with traditional rigid patch formats. Pharmaceutical manufacturers are investing heavily in combination products that merge monitoring capabilities with controlled drug administration. Pediatric and geriatric patient populations represent additional opportunity segments because transdermal delivery reduces swallowing difficulties and simplifies medication management. Improved permeation enhancement technologies, breathable adhesive layers, and biocompatible silicone formulations continue expanding application potential. These developments create significant Transdermal Adhesives Market Forecast opportunities for manufacturers specializing in high-performance medical adhesive technologies.

CHALLENGE

"Complex Formulation Requirements and Regulatory Compliance"

The Transdermal Adhesives Market faces ongoing challenges related to formulation complexity and stringent regulatory requirements. Pharmaceutical-grade adhesives must simultaneously provide strong skin adhesion, chemical compatibility, controlled drug release, moisture resistance, and minimal irritation. Achieving all these performance parameters within a single formulation remains technically demanding. More than 40% of development projects require multiple formulation revisions before meeting target performance standards. Regulatory authorities mandate extensive biocompatibility, toxicity, stability, and adhesion testing before commercialization. Product developers must evaluate adhesive performance across different skin types, environmental conditions, and wear durations. Manufacturing consistency is another critical challenge because slight formulation variations can affect drug delivery efficiency and adhesion reliability. The increasing complexity of combination products involving sensors, microelectronics, and therapeutic components further expands development requirements. These challenges increase development timelines and technical barriers for companies seeking to enter the Transdermal Adhesives Market Outlook landscape.

Transdermal Adhesives Market Segmentation

The Transdermal Adhesives Market is segmented by adhesive chemistry and end-use application requirements. Segmentation helps manufacturers optimize adhesion performance, drug compatibility, moisture resistance, and skin tolerability. Acrylic formulations dominate pharmaceutical patch production because of broad compatibility with active ingredients. Silicone-based materials are increasingly selected for sensitive-skin applications and long-wear therapeutic systems. Rubber-based adhesives continue serving cost-sensitive and specialized medical applications requiring strong initial tack. Across applications, pain management, hormone therapy, cardiovascular treatment, smoking cessation, and neurological drug delivery represent major demand segments. Continuous innovation in adhesive technology supports growing adoption throughout the Transdermal Adhesives Market Analysis environment.

Download FREE Sample to learn more about this report.

BY TYPE

Silicon Base: Silicone-based transdermal adhesives are increasingly utilized in advanced pharmaceutical and medical device applications because of their superior skin compatibility and atraumatic removal properties. Approximately 70% of sensitive-skin patch formulations employ silicone technologies to minimize irritation risks. These adhesives maintain stable performance across a broad temperature range and can retain more than 90% adhesion effectiveness during extended wear periods. Clinical evaluations indicate that silicone adhesives can reduce skin stripping effects by nearly 25% compared with conventional alternatives. Their moisture vapor permeability characteristics improve wearer comfort by facilitating skin breathability. Silicone formulations are commonly selected for hormone therapy patches, specialty pain management systems, and wearable healthcare devices requiring continuous skin contact. More than 35% of next-generation smart patch development programs evaluate silicone materials because of their flexibility and compatibility with integrated sensors. Manufacturers continue improving crosslinking technologies and polymer structures to enhance adhesion consistency while maintaining gentle removal properties. The growing emphasis on patient comfort, dermatological safety, and wearable therapeutic systems is strengthening demand for silicone-based adhesive solutions throughout the global healthcare sector.

Acrylic: Acrylic-based adhesives remain the most widely used category within the Transdermal Adhesives Market due to their excellent balance of adhesion strength, drug compatibility, processing efficiency, and long-term stability. Approximately 62% of pharmaceutical transdermal systems utilize acrylic formulations as their primary adhesive platform. These materials demonstrate strong compatibility with a broad range of active pharmaceutical ingredients and can maintain stable adhesion for periods exceeding five days under normal usage conditions. Acrylic technologies are extensively employed in nicotine replacement therapies, pain management patches, cardiovascular medications, and hormone replacement products. Laboratory evaluations indicate that optimized acrylic formulations can achieve adhesion retention rates above 95% throughout intended wear durations. Their versatility enables customization of tack, cohesion, permeability, and moisture resistance properties according to therapeutic requirements. More than 50% of newly patented transdermal adhesive innovations continue incorporating acrylic chemistry because of established regulatory acceptance and manufacturing scalability. Ongoing advancements in solvent-free processing, low-residue formulations, and skin-friendly polymer modifications further strengthen the position of acrylic adhesives across pharmaceutical drug delivery applications worldwide.

Rubber Base: Rubber-based transdermal adhesives continue serving important roles in specific pharmaceutical and medical applications requiring high initial tack and cost-effective performance characteristics. These formulations account for approximately 15% of adhesive utilization across transdermal systems. Rubber-based materials provide rapid skin attachment and strong immediate bonding performance, making them suitable for short-duration therapeutic applications. Adhesion testing demonstrates that certain rubber formulations can achieve initial tack levels approximately 20% higher than alternative adhesive chemistries. Manufacturers frequently incorporate synthetic rubber technologies to improve stability, oxidation resistance, and compatibility with pharmaceutical ingredients. These adhesives are used in selected pain relief products, specialty therapeutic patches, and medical fixation applications. Product developers are enhancing formulation purity and reducing potential sensitization concerns through advanced polymer processing methods. Improved antioxidant systems and refined manufacturing techniques have increased performance consistency by more than 15% in recent product generations. Although acrylic and silicone technologies dominate many premium applications, rubber-based adhesives continue offering practical solutions for manufacturers seeking reliable adhesion performance and efficient production economics within targeted therapeutic segments.

BY APPLICATION

Hospital: Hospitals represent the largest application segment within the Transdermal Adhesives Market due to extensive utilization of transdermal therapeutic systems across inpatient and outpatient treatment programs. More than 72% of long-duration pain management patches are prescribed and administered through hospital networks. Approximately 68% of post-operative pain therapies involving transdermal delivery systems are monitored within hospital environments because of the need for continuous patient observation and dosage optimization. Cardiovascular treatment patches account for nearly 21% of transdermal products used in hospital settings, while hormone therapy applications contribute approximately 17%. Hospitals increasingly prefer advanced acrylic and silicone adhesive technologies capable of maintaining secure skin attachment for periods exceeding 96 hours, with adhesion retention rates above 94%. Clinical evaluations indicate that transdermal delivery systems can improve medication compliance by nearly 26% compared with conventional dosing schedules among hospitalized patients. More than 58% of hospital pharmacy departments have expanded the availability of patch-based therapeutics due to simplified administration and reduced dosing errors. Skin-friendly adhesive formulations are increasingly preferred, with approximately 43% of procurement programs emphasizing low-irritation products. The growing prevalence of chronic diseases, increasing surgical procedures, and rising adoption of non-invasive drug delivery systems continue to strengthen demand for transdermal adhesives across hospital applications.

Clinic: Clinics represent a significant application segment in the Transdermal Adhesives Market as healthcare providers increasingly adopt convenient and patient-friendly therapeutic delivery methods. Approximately 61% of outpatient pain management therapies in specialized clinics incorporate transdermal treatment options to improve treatment adherence and reduce administration complexity. Dermatology clinics account for nearly 18% of adhesive patch utilization due to increasing demand for skin-compatible therapeutic systems. Endocrinology and hormone replacement treatment centers contribute approximately 24% of clinic-based transdermal applications. More than 54% of outpatient treatment providers report improved patient satisfaction when utilizing patch-based drug administration compared with multiple daily oral doses. Clinical studies indicate that adherence rates in outpatient environments can exceed 85% when transdermal delivery systems are prescribed for chronic therapies. Silicone-based adhesive demand within clinics has increased by approximately 29% because of enhanced comfort and reduced skin trauma during patch removal. Nearly 47% of specialty clinics prioritize adhesive formulations capable of maintaining effective skin contact during normal daily activities. The increasing focus on preventive healthcare, chronic disease management, and ambulatory treatment programs continues supporting broader utilization of advanced transdermal adhesive solutions throughout clinic environments worldwide.

Other: The other application segment includes home healthcare settings, rehabilitation centers, nursing facilities, sports medicine centers, and specialty healthcare institutions utilizing transdermal therapeutic systems. Approximately 64% of long-term transdermal therapy users administer medications independently within home-care environments, highlighting the importance of reliable adhesive performance. Home healthcare applications account for nearly 38% of total non-hospital transdermal patch usage due to increasing demand for self-administered therapies. Rehabilitation centers contribute approximately 14% of specialized adhesive consumption, particularly in pain management and musculoskeletal treatment programs. More than 57% of elderly patients receiving chronic medication management prefer transdermal systems because of simplified administration requirements. Advanced adhesive technologies used in home settings maintain attachment effectiveness above 92% during routine physical activity and environmental exposure. Nearly 41% of wearable therapeutic devices introduced for home healthcare integrate pharmaceutical-grade transdermal adhesive components. Nursing care facilities increasingly adopt extended-wear patches that reduce caregiver intervention frequency by approximately 23%. Growing aging populations, rising demand for remote patient management, and increasing acceptance of self-care treatment approaches continue expanding opportunities for transdermal adhesive utilization across diverse healthcare environments beyond traditional clinical settings.

Transdermal Adhesives Market Regional Outlook

Download FREE Sample to learn more about this report.

North America

North America remains the leading regional market for transdermal adhesives due to advanced pharmaceutical manufacturing capabilities, extensive adoption of transdermal therapeutic systems, and strong healthcare infrastructure. The region contributes approximately 39% of global demand for pharmaceutical-grade transdermal adhesive materials. More than 67% of commercially available transdermal therapies in the region utilize advanced acrylic adhesive formulations, while silicone-based systems account for approximately 24%. Chronic disease prevalence affects over 60% of adults, supporting continued utilization of long-duration therapeutic patches. Nearly 52% of pharmaceutical companies developing transdermal drug delivery products maintain manufacturing or research operations within North America. Adhesive technologies designed for extended wear periods exceeding 72 hours account for approximately 48% of new product evaluations. Skin-friendly and low-irritation formulations represent more than 36% of recently introduced adhesive innovations. Wearable healthcare integration continues expanding, with nearly 31% of development programs incorporating sensor-enabled patch technologies. The region also demonstrates high adoption of smoking cessation, hormone replacement, cardiovascular, and pain management patches, reinforcing demand for premium-performance adhesive solutions.

Europe

Europe represents a mature and technologically advanced market for transdermal adhesives, accounting for approximately 30% of global industry demand. Pharmaceutical manufacturers across the region increasingly prioritize patient-centric drug delivery technologies, resulting in wider adoption of transdermal therapeutic systems. More than 58% of pharmaceutical innovation projects involving patch-based therapies focus on enhanced adhesion performance and skin compatibility. Silicone adhesive utilization has increased by nearly 27% within specialty healthcare applications due to growing demand for atraumatic removal characteristics. Approximately 44% of hospitals and outpatient treatment centers across the region have expanded utilization of non-invasive therapeutic delivery methods. Advanced pressure-sensitive adhesive systems capable of maintaining adhesion effectiveness above 93% during extended wear periods are widely adopted. Nearly 35% of research programs emphasize breathable adhesive structures to improve patient comfort and reduce skin irritation incidence. Aging populations contribute significantly to demand, with individuals above retirement age accounting for more than 22% of healthcare service utilization. Continuous innovation in neurological therapy, cardiovascular treatment, hormone replacement applications, and pain management supports sustained demand for transdermal adhesive technologies throughout Europe.

Asia-Pacific

Asia-Pacific is emerging as a major growth center for transdermal adhesives due to expanding pharmaceutical manufacturing activities, increasing healthcare access, and rising chronic disease prevalence. The region contributes more than 24% of global adhesive demand and continues to strengthen its manufacturing capabilities. Approximately 49% of newly established pharmaceutical production facilities in emerging healthcare economies include capabilities for patch-based therapeutic systems. Demand for acrylic-based transdermal adhesives exceeds 60% because of their compatibility with large-scale pharmaceutical manufacturing operations. More than 55% of healthcare providers report increasing acceptance of non-invasive treatment options among patients. Home healthcare applications account for approximately 33% of transdermal therapy utilization, reflecting growing consumer awareness and self-medication trends. Silicone adhesive adoption has increased by nearly 25% due to improved patient comfort characteristics. More than 40% of regional product development activities focus on cost-effective adhesive technologies without compromising therapeutic performance. Rising prevalence of diabetes, cardiovascular disorders, chronic pain conditions, and hormonal imbalances continues supporting broader utilization of transdermal therapeutic systems and associated adhesive materials throughout Asia-Pacific healthcare markets.

Middle East & Africa

The Middle East & Africa region is experiencing steady expansion in transdermal adhesive adoption due to healthcare infrastructure modernization and increasing awareness of advanced drug delivery technologies. Approximately 18% of pharmaceutical procurement programs in major healthcare facilities now include transdermal therapeutic systems for chronic disease management. More than 42% of healthcare institutions prioritize non-invasive treatment alternatives to improve patient compliance and reduce administration complexity. Acrylic adhesive formulations account for nearly 63% of transdermal applications within the region because of established pharmaceutical compatibility and cost efficiency. Silicone-based solutions contribute approximately 19% of specialty applications involving sensitive skin and extended wear requirements. Hospital-based utilization exceeds 57% of total regional transdermal therapy deployment. Nearly 28% of healthcare modernization projects include expanded access to advanced therapeutic technologies. Home healthcare services continue growing, accounting for approximately 21% of transdermal patch consumption. Increased investment in pharmaceutical manufacturing, rising prevalence of chronic illnesses, and broader adoption of patient-friendly therapeutic solutions are strengthening the long-term outlook for transdermal adhesive technologies across the Middle East & Africa region.

List of Key Transdermal Adhesives Market Companies

• 3M
• Adhesives Research
• Adhex Technologies
• DuPont
• Elkem
• Henkel
• Lohmann GmbH & Co.KG
• Nitto Denko Corporation

Top Companies with Highest Market Share

• 3M: Holds an estimated market participation exceeding 18% within pharmaceutical-grade transdermal adhesive applications. More than 42% of its healthcare adhesive portfolio focuses on skin-contact technologies, while product adhesion reliability rates exceed 95% across long-duration therapeutic applications.
• Henkel: Represents approximately 14% of industry participation in specialty medical adhesive solutions. Nearly 37% of development activities are directed toward advanced pressure-sensitive technologies, while skin-compatible formulations account for more than 46% of healthcare-focused adhesive innovations.

Investment Analysis and Opportunities

The Transdermal Adhesives Market continues attracting strategic investments due to increasing demand for patient-friendly drug delivery technologies and wearable healthcare integration. Approximately 48% of industry investment initiatives focus on development of skin-compatible adhesive formulations with reduced irritation characteristics. More than 41% of research allocations are directed toward extended-wear performance enhancement, moisture resistance improvements, and breathable adhesive structures. Pharmaceutical companies increasingly prioritize matrix patch technologies, accounting for nearly 35% of ongoing innovation programs. Investments in silicone-based adhesive platforms have increased by approximately 28% because of growing utilization in sensitive-skin and long-duration therapeutic applications.

Emerging opportunities are linked to personalized medicine, smart patch technologies, and home healthcare expansion. Nearly 44% of wearable therapeutic device developers are evaluating integrated adhesive systems capable of maintaining effective skin contact during continuous monitoring. More than 32% of healthcare innovation programs focus on combination products incorporating sensors and therapeutic delivery functions. Demand for low-residue adhesives has increased by approximately 26%, creating opportunities for specialized material manufacturers. The expansion of chronic disease management programs, aging populations, and self-administered therapies continues supporting long-term investment potential across the transdermal adhesives value chain.

New Products Development

Product development activities within the Transdermal Adhesives Market increasingly emphasize skin safety, extended wear duration, and compatibility with advanced pharmaceutical formulations. Approximately 46% of newly introduced adhesive technologies focus on minimizing skin irritation while maintaining adhesion effectiveness above 94% throughout intended wear periods. Silicone-enhanced formulations account for nearly 29% of recent development projects because of their gentle removal characteristics and flexibility. More than 38% of innovation initiatives target moisture-resistant adhesives designed for active lifestyles and challenging environmental conditions.

Advanced breathable adhesive structures have demonstrated improvements in wearer comfort exceeding 22% compared with traditional configurations. Nearly 34% of newly evaluated products incorporate low-allergen components to address sensitivity concerns among long-term users. Smart therapeutic patches integrating microelectronics and monitoring capabilities represent approximately 17% of ongoing product development programs. Manufacturers are also improving solvent-free processing methods, with adoption rates increasing by nearly 24% across development pipelines. These innovations support broader utilization of transdermal therapeutic systems in pain management, hormonal therapy, cardiovascular treatment, neurological disorders, and wearable healthcare applications.

Five Recent Developments (2023-2025)

• Advanced Silicone Adhesive Platform Expansion: During 2024, manufacturers expanded silicone-based transdermal adhesive portfolios with fo

  Transdermal Adhesives Market Report Coverage

  REPORT COVERAGE	DETAILS
  Market Size Value In	USD 83.46 Million in 2026
  Market Size Value By	USD 135.77 Million by 2035
  Growth Rate	CAGR of 5.56% from 2026 - 2035
  Forecast Period	2026 - 2035
  Base Year	2025
  Historical Data Available	Yes
  Regional Scope	Global
  Segments Covered
  	By Type Silicon Base Acrylic Rubber Base
  	By Application Hospital Clinic Other